19 May 2013
Keywords: lilly, adhd, product, approvable, says, fda, food
Article | 19 August 2002
The US Food and Drug Administration has sent Eli Lilly an approvablenotice for Strattera (atomoxetine hydrochloride), a non-stimulant
treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 August 2002
12 August 2002
17 May 2013
© 2013 thepharmaletter.com